Beamtree Holdings Ltd · ASX:BMT
Beamtree — Investor Presentation (August 2021)
35 slides from Beamtree's investor presentation, Aug 27, 2021
Slide 1: Better has no limit
Better has no limit Beamtree Investor Presentation FY21
Slide 2: Beamtree enjoyed a record year in FY21
Beamtree enjoyed a record year in FY21 Beamtree products are helping providers improve the efficiency of their We have won major Retention services, deliver better quality care and minimise waste to reinvest into health contracts in Australia and renewals for the benefit of all. and internationally
Slide 3: From PKS to Beamtree
From PKS to Beamtree Beamtree is the new name We believe Beamtree reflects Beamtree echoes our values – to assist in for this well-established our mission to use data to the constant evolution and improvement Australian pioneer as it illuminate pathways to better of healthcare through best-in-class
Slide 4: Record growth and global impact FY21
International expansion Key acquisition Record growth and global Winning first national data quality Ainsoff impacting patient care impact FY21 audit in Kingdom of Saudi Arabia through AI. (TCV AUD$2.25m), following success in Ireland and Singapore. Beamtree a proud Australian company supporting cus
Slide 5: Financial Summary FY21
Financial Summary FY21 +109% growth in ARR 15% group’s revenue and Growth* 20% YoY on pro- Continued annualised forma basis* recurring revenue growth YoY Strong total revenue performance $8.9 million 34% operational 78% recurring EBITDA margin revenue A$3.1 million Exceeded management forecast 99% c
Slide 6: FY21 Highlights
FY21 Highlights Winning customers International expansion Major new client wins for PICQ® (data quality) and Winning first national data RISQTM (benchmarking services) quality audit in Kingdom of in Australian hospitals. These Saudi Arabia (TCV AUD$2.25m), services now assess around following succes
Slide 7: Beamtree delivered strong growth while maintaining a trusted core of customers
Beamtree delivered strong growth while maintaining a trusted core of customers May St Vincent’s Health Australia reveals 16% reduction 2020 2021 February in hospital acquired Investment for complications (HACs) with growth plan support of RISQTM launched July November New agreement AUD$2.25m for hea
Slide 8: Investing in global skills and experience to accelerate our strategy
Investing in global skills and experience to accelerate our strategy Our workforce increased by 83% in FY21. The Beamtree team deliver impact and provide expertise in their fields, to boost the strategy, planning and market opportunities. Introducing some of our new Team from FY21 CEO Chief Strategy
Slide 9: Our people
Our people Growing our strategy Introducing some of our new Team from FY21 Head of International Advisory Head of International Strategy Chair of the Beamtree Global Jennifer Nobbs and BD Impact Committee Alex Kafetz Mark Britnell Based in the UK, Jennifer is engaging with new and Alex is a campaign
Slide 10: Key acquisition impacting patient care through AI
Clinical trial outcomes Key acquisition impacting The first of the Ainsoff products patient care through AI performed better than existing early warning systems. It demonstrated greater specificity and significantly reduced the number of false The expert clinical team from alarms, enabling targeted
Slide 11: How Beamtree creates value and solve problems
Product portfolio How Beamtree creates value and solve problems: data, insights, action to drive better decisions
Slide 12: The Beamtree difference
The Beamtree difference At Beamtree, we understand how to collect and integrate data, how to improve quality and interpret information to focus on insights essential to better decision-making. We understand how knowledge flows, how it is managed and how it is used. We know what it takes to deliver b
Slide 13: How we create value
How we create value Return knowledge to Collect health The Learning Health System the rules engine information Support clinicians Encode in coders and standard formats administrators in their workflow Use in workflows and Monitor for quality learn from use and correct in use Develop intelligent Math
Slide 14: Better has no limit: the problems we solve
Better has no limit: the problems we solve We empower the learning health The best health services deliver value for system – turning data into insight money by reducing avoidable mortality, and action through automation. waste, length of stay, readmissions and cost of care. Beamtree is in a unique
Slide 15: Our products
Our products “Achieving high value to patients and health providers must become the overarching goal of health care delivery, with value improving the outcomes We make it simple for healthcare providers achieved for the investment made.” to access quality information, to automate Michael E Porter wh
Slide 16: About us
About us Beamtree mobilises the power of data and automation for a healthier, happier world.
Slide 17: Spotlight on products
“RISQ has helped drive Spotlight on products a 16% reduction in overall hospital acquired complications and reduce pressure injuries by 70%.” “We’re on a mission to reduce HACs and provide the best care. It starts Auditing the quality of clinical data Benchmarking best practice in with good data.” c
Slide 18: Product Value
Product Value “RippleDown has led to considerable savings and revenue enhancements for Lancet: correcting errors identified, guiding clinicians and automating documentation. The financial and workforce benefits are incredible.” Providing real-time clinical support Lancet Laboratories, South Africa A
Slide 19: The Three Pillars of growth actioned in FY21
Our growth strategy The Three Pillars of growth actioned in FY21
Slide 20: Three pillars of growth
Three pillars of growth Domestic $117m International $3.5bn Domestic $210m, International $6.3bn Domestic $100m, International $3.8bn Scale the Core Leverage the Core Expand the Core - expansion - innovation - transformation Rapidly scale our core products Develop new complementary products Accelera
Slide 21: Implementing the growth strategy
Implementing the growth strategy Automation of Global analytics coding Innovating AI and decision support International Building research success and thought leadership 21 FY21 Investor Presentation Copyright © Beamtree – All Rights Reserved
Slide 22: Spotlight on the automation of coding
Implementing the growth strategy: Spotlight on the automation of coding At Beamtree we are working on a near-term future in which health systems start to move from a world of post- Beamtree has always discharge data classification to concurrent computer- assisted coding. This will empower real-time
Slide 23: Spotlight on new insights platform
Implementing the growth strategy: Spotlight on new insights platform Insights Platform Global Insights Over 20 countries are already engaged – some nationwide – as customers Tracking best practice, learning Decades of combined experience, with from peers and driving quality. unique science to show a
Slide 24: Spotlight on innovating AI and decision support
Implementing the growth strategy: Spotlight on innovating AI and decision support Artifical intelligence, machine learning and automation Beamtree has been successful in implementing long- — we will use CDS in analytics tools to Beamtree is term use of artificial intelligence in clinical services tr
Slide 25: Spotlight on International Success
Spotlight on International Success Over 20 countries are already engaged - some nationwide - as customers for Beamtree solutions. Beamtree has partnered Clinically coded data is essential to ensure that resources are used with International Health Ministries and global distributors and planned for e
Slide 26: Spotlight on building research and thought leadership
Implementing the growth strategy: Spotlight on building research and thought leadership Beamtree will launch its Global Impact Committee in October 2021, to be chaired by international health About Mark Britnell expert, leader and award-winning author Dr Mark Britnell. Committee membership will be d
Slide 27: Transforming knowledge management in healthcare
Transforming knowledge management in healthcare. Building on world-class core products to develop an integrated platform for information and knowledge management, empowering a learning health system, providing end-to- end support from the moment of data collection and classification through quality
Slide 28: Financial results FY21
Finance Financial results FY21
Slide 29: FY21 vs FY20 financials
Actual Actual YoY YoY Actual LY FY21 vs FY20 financials $(,000) FY20 FY21 Var $ Var % Pro-forma Subscription, License & Usage Revenue - recurring 3,810 6,138 2,328 61% 5,523 Commentary Service Revenue - recurring - 448 448 nmf 406 Consultancy & Initial license fee Revenue — Total Revenue was $8.9m,
Slide 30: Revenue performance
Revenue performance FY21 Revenue FY21 ARR Growth PCP Composition FY21 Annualised Recurring Revenue (ARR) Growth 8 73% License, Subscription and 7 Usage - recurring 6 21% Consultancy and 5 one-off license $m 4 6% 3 Service – recurring 2 1 0 FY19 FY20 FY21 Comment — Revenue from direct customers now —
Slide 31: Investing in innovation
Investing in innovation FY20 FY21 FY20 FY21 FY20 FY21 Headcount 40 30 Comments 20 — Investment in Product and Technology to enhance product capabilities for future growth 10 — Investment in Sales & Marketing to further grow a strong pipeline and direct go-to-market capabilities 0 — Growth in Ops mai
Slide 32: Balance Sheet
Balance Sheet Comments 30 June 2021 30 June 2020 — Well funded for growth Assets — Cash position of $14m as at 30 June 2021 and zero debt Current assets — Debtors balance as at Jun21 includes first milestone invoice Cash and cash equivalents 14,117 4,205 of $360k AUD on KSA project and payment is fu
Slide 33: Cashflow
Cashflow FY21 FY20 Comments Receipts from customers (inclusive of GST) 7,351 3,831 Operating cashflow Payments to suppliers and employees (inclusive of GST) (7,714) (2,837) — Milestone payments on KSA project has a timing Other 603 52 impact on operating cashflow in FY21. First Net cash from / (used
Slide 34: Important Notice and Disclaimer
Important Notice and Disclaimer The material in this presentation is general background information about Beamtree Holdings Limited (ASX:BMT) and is current at the date of the presentation, 27 August 2021. This presentation may contain statements that are, or may be deemed to be, forward looking sta
Slide 35: Thank you
Thank you Beamtree Investor Presentation FY21
Beamtree Holdings — Investor Presentation (August 2021) on 6ix